Polynucleotide detection by isothermal amplification using cleavable oligonucleotides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5747255
SERIAL NO

08536743

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for detecting a target polynucleotide is provided which relies on the exponential amplification of oligonucleotide fragments. Separated populations of oligonucleotides are provided that contain complementary sequences to one another and that contain at least one scissile linkage which is cleaved whenever a perfectly matched duplex is formed containing the linkage. When a target polynucleotide contacts a first oligonucleotide cleavage occurs and a first fragment is produced which can hybridize with a second oligonucleotide. Upon such hybridization, the second oligonucleotide is cleaved releasing a second fragment that can, in turn, hybridize with a first oligonucleotide in a manner similar to that of the target polynucleotide. Upon such hybridization, cleavage again occurs and an additional first fragment is produced which can hybridize

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LYNX THERAPEUTICS INC3832 BAY CENTER PLACE HAYWARD CA 94545 UNITED STATES OF AMERICA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brenner, Sydney Cambridge, GB2 108 21860

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation